Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Nasal spray of gold nanoparticles delivers lithium directly to the brain

Nasal spray of gold nanoparticles delivers lithium directly to the brain

Largest study of African American brain tissue reveals key Alzheimer gene activity

Largest study of African American brain tissue reveals key Alzheimer gene activity

Nanotechnology breakthrough reverses Alzheimer’s disease in mice

Nanotechnology breakthrough reverses Alzheimer’s disease in mice

Investigating cannabidiol's role in combating Alzheimer's-related neuroinflammation

Investigating cannabidiol's role in combating Alzheimer's-related neuroinflammation

Cell messengers signal amyloid plaque buildup in obese individuals

Cell messengers signal amyloid plaque buildup in obese individuals

Study links high neuroinflammation in young people with Down Syndrome to Alzheimer's risk

Study links high neuroinflammation in young people with Down Syndrome to Alzheimer's risk

Scientists discover new protein family regulating motility and DNA uptake

Scientists discover new protein family regulating motility and DNA uptake

Thermo Fisher Scientific expands neurodegeneration research capabilities with launch of Olink® Target 48 Neurodegeneration panel

Thermo Fisher Scientific expands neurodegeneration research capabilities with launch of Olink® Target 48 Neurodegeneration panel

Molecular fingerprint predicts physical fitness in older adults

Molecular fingerprint predicts physical fitness in older adults

New evidence shows blood-brain barrier remains intact in Alzheimer's mouse model

New evidence shows blood-brain barrier remains intact in Alzheimer's mouse model

Study shows how early-life epigenetic 'memory' can influence adult brain inflammation

Study shows how early-life epigenetic 'memory' can influence adult brain inflammation

Mount Sinai study maps protein networks driving Alzheimer’s disease pathogenesis

Mount Sinai study maps protein networks driving Alzheimer’s disease pathogenesis

COVID-19 linked to long-lasting reductions in smell even without noticeable symptoms

COVID-19 linked to long-lasting reductions in smell even without noticeable symptoms

Healthy habits linked to younger brain age

Healthy habits linked to younger brain age

Groundbreaking MRI technique reveals microvascular pulsations in the aging brain

Groundbreaking MRI technique reveals microvascular pulsations in the aging brain

New research explores pre-diagnostic indicators of dementia

New research explores pre-diagnostic indicators of dementia

Scientists map step-by-step activation of brain receptors

Scientists map step-by-step activation of brain receptors

Influenza infection in pregnant mice linked to fetal brain exposure

Influenza infection in pregnant mice linked to fetal brain exposure

University of Utah launches landmark study linking blood pressure and brain health

University of Utah launches landmark study linking blood pressure and brain health

Innovative technique could reveal Alzheimer’s before symptoms appear

Innovative technique could reveal Alzheimer’s before symptoms appear

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.